← Back to Screener
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD)
Price$0.52
Growth ScoreF
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-63.46%
Price vs S&P 500 (4W)-27.09%
VGM Score24.91
Market Capitalization$6.05M
All Metrics
P/CF (Annual)10.63x
Book Value / Share (Quarterly)$0.47
P/TBV (Annual)2.43x
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-48.15%
10-Day Avg Trading Volume0.03M
EPS (Annual)$-0.00
ROI (Annual)-0.37%
Gross Margin (Annual)21.81%
Cash / Share (Quarterly)$0.02
Revenue Growth QoQ (YoY)-35.65%
ROA (Last FY)-0.29%
Cash Flow / Share (Annual)$0.04
P/B Ratio1.18x
P/B Ratio (Quarterly)3.14x
Net Income / Employee (Annual)$-1,000
Net Interest Coverage (TTM)1.25x
EPS Incl Extra (Annual)$-0.00
Current Ratio (Annual)2.99x
Quick Ratio (Quarterly)2.51x
3-Month Avg Trading Volume0.11M
52-Week Price Return-71.82%
EV / Free Cash Flow (Annual)19.63x
Tangible BV / Share (Quarterly)$0.46
P/S Ratio (Annual)0.48x
Asset Turnover (Annual)3.69x
52-Week High$2.76
EPS Excl Extra (Annual)$-0.00
26-Week Price Return-49.88%
Quick Ratio (Annual)2.74x
13-Week Price Return-21.15%
Total Debt / Equity (Annual)0.48x
Current Ratio (Quarterly)2.93x
Enterprise Value$8.13M
Revenue / Employee (Annual)$465,000
Pretax Margin (Annual)8.13%
Cash / Share (Annual)$0.07
3-Month Return Std Dev80.64%
ROE (Last FY)-0.54%
EPS Basic Excl Extra (Annual)$-0.00
Total Debt / Equity (Quarterly)0.44x
Revenue / Share (Annual)$1.14
Tangible BV / Share (Annual)$0.44
Price vs S&P 500 (52W)-99.97%
Year-to-Date Return-36.77%
5-Day Price Return-3.80%
EPS Normalized (Annual)$-0.00
Net Profit Margin (Annual)7.95%
Month-to-Date Return-0.70%
EBITD / Share (Annual)$0.11
Operating Margin (Annual)8.31%
LT Debt / Equity (Annual)0.30x
LT Debt / Equity (Quarterly)0.26x
P/TBV (Quarterly)3.20x
P/B Ratio (Annual)2.38x
Book Value / Share (Annual)$0.45
Price vs S&P 500 (13W)-31.81%
Beta1.34x
P/FCF (Annual)14.60x
52-Week Low$0.37
gGradeF
mGradeD
vgmGradeD
Show chart for
Industry Peers — Drug Wholesale(9)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares | — | F | D | $0.52 |
| MCKMcKesson Corporation | D | B | C | $739.53 |
| CORCencora, Inc. | D | B | D | $263.64 |
| CAHCardinal Health, Inc. | C | C | C | $195.85 |
| HLFHerbalife Ltd. | B | D | C | $11.39 |
| NUSNuSkin Enterprises, Inc. | A | F | D | $5.28 |
| COSMCosmos Holdings Inc. Common Stock | D | B | D | $0.25 |
| ZSTKZeroStack Corp. Common Stock | — | F | D | $4.90 |
| WGRXWellgistics Health, Inc. Common Stock | D | F | F | $4.39 |
| HWHHWH International Inc. Common Stock | F | F | D | $1.02 |
About
Cellyan Biotechnology Co Ltd operates OTC pharmaceutical supply chain and distribution services for cross-border e-commerce in Mainland China. Through its subsidiaries Joint Cross Border and V-Alliance, the company provides supply chain services and procurement/distribution capabilities, serving importers and e-commerce platforms in this growing market.